Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

Current Issue

March 2026 (Vol. 46 Issue 3) Table of Contents
Anticancer Research: 46 (3)

Issue highlights

  • Cytostatic Benzylidene-isophthaloylhydazides With Diminished Neurotoxicity
  • SLFN11 Drives GM-CSF–mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma
  • Primary Debulking Surgery Versus Interval Debulking Surgery in the Management of Advanced-Stage Ovarian Cancer
  • Risk of Non-colorectal Malignancies in Sporadic Versus Lynch Syndrome–associated dMMR Colorectal Cancer
  • Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells

 


 

New Special Issue on "​Ovarian Cancer Immunology and Immunotherapy– 2026"

Submission deadline: February 15, 2026;

Publication date: May 2026. ​

Click here for more information.

Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • You have access
    Dual Role of PSMB9 Linking Immune Activation and Tumor Adaptation in Hepatocellular Carcinoma With Therapeutic and Prognostic Implications
    YITING LIU, JIAOJIAO CAO, HAIYANG YU, QICHEN SUN, TIANYI ZHU, YU ZHOU, XIAOYI DING, JIAN WANG, XIAOXIA GUO and ZHIYUAN WU
    Anticancer Research March 2026, 46 (3) 1389-1410; DOI: https://doi.org/10.21873/anticanres.18036
  • You have access
    Erlotinib Induces Cell Death by Blocking NIX-mediated Mitophagy Through Lysosomal Swelling in IDH1-mutant Cholangiocarcinoma
    YONGHYUN KANG, CHORONG KIM, CHAN YEOP JEONG, DA SOL LEE, CHANGHOON YOO, INKEUN PARK, SEONMIN LEE and KYU-PYO KIM
    Anticancer Research March 2026, 46 (3) 1349-1364; DOI: https://doi.org/10.21873/anticanres.18034
  • You have access
    Mechanistic Studies of Anticancer Effects of Salicylaldehyde Benzoylhydrazone in 2D/3D Lung Cancer Cell Cultures
    WANNAPA SANGSEEKEW, JUTATIP BOONSOMBAT, SANIT THONGNEST, JITNAPA SIRIRAK, THIWAREE SORNPRACHUM, KRIENGSAK LIRDPRAPAMONGKOL, JISNUSON SVASTI, SOMSAK RUCHIRAWAT and SIRIPORN KEERATICHAMROEN
    Anticancer Research March 2026, 46 (3) 1365-1387; DOI: https://doi.org/10.21873/anticanres.18035
  • You have access
    Long-term Outcomes and Functional Limitations of Liquid Nitrogen–treated Autografts in Limb Salvage Surgery for Bone Malignancies
    MASANORI KAWANO, YUTA KUBOTA, ICHIRO ITONAGA, NOBUHIRO KAKU and KAZUHIRO TANAKA
    Anticancer Research March 2026, 46 (3) 1591-1598; DOI: https://doi.org/10.21873/anticanres.18054
  • You have access
    Immunohistochemical Expression and Clinicopathological Assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 Expression in Desmoid Tumor
    KAZUHIKO HASHIMOTO, SHUNJI NISHIMURA, HIROKI TAN, TOMOHIKO ITO and KOJI GOTO
    Anticancer Research March 2026, 46 (3) 1411-1419; DOI: https://doi.org/10.21873/anticanres.18037
  • You have access
    Plan Quality Variability in Radiotherapy of Whole Breast and Regional Lymph Nodes: An Intra-institutional Analysis
    GRACINDA JOHANSSON and ARIADNI KYRIAKOGIANNAKI
    Anticancer Research March 2026, 46 (3) 1557-1568; DOI: https://doi.org/10.21873/anticanres.18050
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire